WallStreetZenWallStreetZen

NASDAQ: CODX
Co Diagnostics Inc Stock

$1.47+0.02 (+1.38%)
Updated Jun 21, 2024
CODX Price
$1.47
Fair Value Price
$0.05
Market Cap
$45.98M
52 Week Low
$0.98
52 Week High
$1.89
P/E
-1.11x
P/B
0.59x
P/S
5.01x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.68M
Earnings
-$38.89M
Gross Margin
41.3%
Operating Margin
-589.77%
Profit Margin
-582.4%
Debt to Equity
0.11
Operating Cash Flow
-$25M
Beta
0.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CODX Overview

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CODX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CODX ($1.47) is overvalued by 3,090.43% relative to our estimate of its Fair Value price of $0.05 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CODX ($1.47) is not significantly undervalued (3,090.43%) relative to our estimate of its Fair Value price of $0.05 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CODX due diligence checks available for Premium users.

Be the first to know about important CODX news, forecast changes, insider trades & much more!

CODX News

Valuation

CODX fair value

Fair Value of CODX stock based on Discounted Cash Flow (DCF)
Price
$1.47
Fair Value
$0.05
Overvalued by
3,090.43%
CODX ($1.47) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CODX ($1.47) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CODX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.11x
Industry
30.89x
Market
30.75x

CODX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.59x
Industry
3.91x
CODX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CODX's financial health

Profit margin

Revenue
$467.9k
Net Income
-$9.3M
Profit Margin
-1,990.4%
CODX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CODX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$86.7M
Liabilities
$8.3M
Debt to equity
0.11
CODX's short-term assets ($53.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CODX's short-term assets ($53.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CODX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CODX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$8.5M
Investing
$16.7M
Financing
$0.0
CODX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CODX vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
CODX$45.98M+1.38%-1.11x0.59x
COCH$44.88M-4.58%-10.90x-6.05x
XAIR$44.69M-5.34%-0.58x2.15x
APYX$47.81M+3.76%-2.09x2.36x
CTSO$43.45M+1.14%-1.36x2.30x

Co Diagnostics Stock FAQ

What is Co Diagnostics's quote symbol?

(NASDAQ: CODX) Co Diagnostics trades on the NASDAQ under the ticker symbol CODX. Co Diagnostics stock quotes can also be displayed as NASDAQ: CODX.

If you're new to stock investing, here's how to buy Co Diagnostics stock.

What is the 52 week high and low for Co Diagnostics (NASDAQ: CODX)?

(NASDAQ: CODX) Co Diagnostics's 52-week high was $1.89, and its 52-week low was $0.98. It is currently -22.22% from its 52-week high and 49.85% from its 52-week low.

How much is Co Diagnostics stock worth today?

(NASDAQ: CODX) Co Diagnostics currently has 31,278,418 outstanding shares. With Co Diagnostics stock trading at $1.47 per share, the total value of Co Diagnostics stock (market capitalization) is $45.98M.

Co Diagnostics stock was originally listed at a price of $5.81 in Jul 12, 2017. If you had invested in Co Diagnostics stock at $5.81, your return over the last 6 years would have been -74.7%, for an annualized return of -20.47% (not including any dividends or dividend reinvestments).

How much is Co Diagnostics's stock price per share?

(NASDAQ: CODX) Co Diagnostics stock price per share is $1.47 today (as of Jun 21, 2024).

What is Co Diagnostics's Market Cap?

(NASDAQ: CODX) Co Diagnostics's market cap is $45.98M, as of Jun 24, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Co Diagnostics's market cap is calculated by multiplying CODX's current stock price of $1.47 by CODX's total outstanding shares of 31,278,418.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.